Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNcc Regulatory News (NCC)

Share Price Information for Ncc (NCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 134.40
Bid: 133.80
Ask: 134.60
Change: 6.60 (5.16%)
Spread: 0.80 (0.598%)
Open: 129.60
High: 137.20
Low: 129.00
Prev. Close: 127.80
NCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic disposal of DetACT

21 Dec 2023 08:02

RNS Number : 6053X
NCC Group PLC
21 December 2023
 

21 December 2023

 

NCC Group plc

Strategic disposal of DetACT

 

NCC Group plc ("NCC" or the "Group"), a people-powered, tech enabled global cyber security and software escrow business, announces the disposal of DetACT, an advanced preventive fraud detection solution for banks in Europe, to DataExpert BV for a total gross consideration of ?9.0m (the "Proposed Disposal").

DetACT is a non-core offering within NCC's European Cyber Security division serving European financial service clients. DetACT's new ownership will provide a focused investment strategy for the business, to enable it to grow and continue to innovate, delivering greater value for existing and future clients.

Mike Maddison, NCC Group CEO, commented:

"The sale of DetACT is part of our ongoing Next Chapter strategy announced in February 2023, which is to release non-core assets from our portfolio and enable us to focus on growing our core business. The management team of DetACT has built a profitable and stable business serving financial services clients in Europe and I am confident that under the new ownership of DataExpert BV they will be in a stronger position to invest in future growth."

Terms of the disposal

NCC Group, through its wholly owned subsidiary Fox-IT Holdings BV, announces the sale of DetACT to DataExpert BV for a total cash consideration of ?9.0m. This is subject to a potential net working capital adjustment and normal completion requirements and is payable on completion in January 2024. The net proceeds (expected to be c.?8.3m) from the transaction will be used to pay down net debt of the Group.

For the full year to 31 May 2023, DetACT generated revenue of c.?5.5m, made an adjusted operating profit of c.?0.8m and had gross assets of c.?18m. All 41 employees including the management team will transfer with the trade and assets.

The disposal involves a Transactional Services Agreement to allow an efficient transition of the business to DataExpert BV.

The disposal constitutes a Class 2 transaction for the purpose of the Financial Conduct Authority's Listing Rules.

Enquiries: 

NCC Group (www.nccgroupplc.com)

+44 (0)7824 412 405

Yvonne Harley

H/Advisors Maitland

+44 (0)20 7379 5151 

Sam Cartwright

 

About NCC Group plc:

 

NCC Group is a people-powered, tech-enabled global cyber security and software escrow business.

 

Driven by a collective purpose to create a more secure digital future, c.2,200 colleagues across Europe, North America and Asia Pacific harness their collective insight, intelligence, and innovation to deliver cyber resilience for over 14,000 clients across the public and private sector globally.

 

With decades of experience and a rich heritage, NCC Group is committed to developing sustainable solutions that continue to meet clients' current and future cyber security challenges.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISUARWROAUUURA
Date   Source Headline
24th Apr 20247:00 amRNSAppointment of Joint Broker
18th Apr 20241:12 pmRNSDirector/PDMR Shareholding
16th Apr 202411:29 amRNSDirector/PDMR Shareholding
15th Apr 20244:04 pmRNSHolding(s) in Company
12th Apr 20241:05 pmRNSHolding(s) in Company
9th Apr 20247:00 amRNSCapital Markets Event for Escode
21st Mar 20244:35 pmRNSDirector Declaration
19th Mar 20241:31 pmRNSDirector/PDMR Shareholding
19th Mar 20249:44 amRNSHolding(s) in Company
12th Mar 20245:35 pmRNSHolding(s) in Company
12th Mar 202412:03 pmRNSHolding(s) in Company
20th Feb 202412:36 pmRNSDirector/PDMR Shareholding
31st Jan 20245:30 pmRNSBlock Listing Six Monthly Return
31st Jan 20243:56 pmRNSTR-1: Holding(s) in Company
29th Jan 20245:45 pmRNSChange of Auditor
25th Jan 20247:00 amRNSUnaudited interim results - period ended 30/11/23
18th Jan 20242:58 pmRNSDirector/PDMR Shareholding
21st Dec 20238:02 amRNSStrategic disposal of DetACT
19th Dec 20234:28 pmRNSDirector/PDMR Shareholding
13th Dec 20231:26 pmRNSDirector/PDMR Shareholding
1st Dec 20234:06 pmRNSDirector/PDMR Shareholding
30th Nov 20231:48 pmRNSResults of the 2023 Annual General Meeting
30th Nov 20237:00 amRNSAGM Trading Statement
21st Nov 20235:09 pmRNSBlock Listing Application
21st Nov 20233:51 pmRNSDirector/PDMR Shareholding
31st Oct 20232:13 pmRNSTotal Voting Rights
31st Oct 202311:44 amRNSDirector/PDMR Shareholding
27th Oct 202312:37 pmRNSDirector/PDMR Shareholder Dealing
24th Oct 20235:10 pmRNSHolding(s) in Company
18th Oct 20232:15 pmRNSDirector/PDMR Shareholding
18th Oct 20232:06 pmRNSDirector/PDMR Shareholding
11th Oct 202312:31 pmRNSHolding(s) in Company
11th Oct 202312:21 pmRNSDirector/PDMR Shareholding
10th Oct 20231:07 pmRNSNotice of Annual General Meeting - 2023
10th Oct 202312:52 pmRNSDirector/PDMR Shareholding
5th Oct 202312:58 pmRNSDirector/PDMR Shareholding
4th Oct 20233:26 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:28 pmRNSHolding(s) in Company
28th Sep 20235:07 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSPreliminary unaudited FY 2023 Results
20th Sep 202310:44 amRNSHolding(s) in Company
19th Sep 20233:24 pmRNSDirector/PDMR Shareholding
19th Sep 202311:35 amRNSHolding(s) in Company
19th Sep 202311:31 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSChange to date of Prelim results & trading update
23rd Aug 20232:02 pmRNSHolding(s) in Company
18th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20233:09 pmRNSBlock listing Interim Review
20th Jul 20234:51 pmRNSHolding(s) in Company
19th Jul 20234:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.